We quantified Iipoprotein(a) [Lp(a)] immunochemically in young (<46 y) male survivors of myocardial infarction and in age-matched controls recruited from participants of the Prospective Cardiovascular M#{252}nster (PROCAM) study. We further determined apolipoprotein E polymorphism and measured triglycerides, total cholesterol, high-and low-density lipoprotein cholesterol (HDL and LDL), and apolipoproteins Al, All, and B in the serum of these subjects. Lp(a) concentrations in serum were not correlated with other well-recognized risk factors for early myocardial infarction such as apolipoproteins Al and B, LDL cholesterol, and HDL cholesterol. Apolipoprotein E polymorphism did not affect Lp(a) concentrations, but had a major influence on apolipoprotein B concentration. Lp(a) concentrations were not influenced by age. Our data suggest that (a) an increased concentration of Lp(a) constitutes an independent risk factor for early myocardial infarction and (b) the concentrations of Lp(a) and LDL cholesterol (apolipoprotein B) in serum are under separate metabolic control. is present in widely varying concentrations in plasma and can be isolated from the 1.055-1.110 kg/L density fraction after preparative ultracentrifugation (1-3). The Lp(a) lipid composition is similar to that of low-density lipoproteins (LDL), but the protein composition is different, consisting of two major proteins, apolipoproteun (ape) B 100 and apo(a) (4, 5). Numerous groups agree in their findings that individuals with increased concentrations of Lp(a) have a higher risk for developing premature coronary heart disease (6-13). The risk for stroke as well as for re-stenosis after coronary artery bypass surgery reportedly (14) (15) (16) correlates highly with increases in Lp(a). It is as yet unknown whether the atherogenicity of Lp(a) originates from its role in lipid metabolism or, because of the similarity of apo(a) to plasmunogen (17-19), its possible influence on the clotting system. We report here that Lp(a) concentrations in serum differ between relatively young survivors of MI and age-matched controls. We found that the concentrations of Lp(a) in serum of both MI survivors 'Institut f#{252}r Klinische Chemie und Laboratonumsmedizun, Zentrallaboratorium, UniversitAtskliniken der Westflischen
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MaterIals and Methods

Subjects.
Sera were collected from 509 survivors of myocardial infarction who had fasted overnight and were hospitalized for rehabilitation at the LVA Fachklinik Saizetal in Bad Salzuflen. All were men younger than 46 years. Blood was sampled within two to four weeks after their release from acute care. At this time, heart-and liver-specific enzyme profiles were normal. Control sera were from 1053 age-matched participants of the Prospective Cardiovascular MOnster (PROCAM) study (20) . Mean body mass index was 26.1 (SD 2.7) and 24.9 (SD 3.1) for the patients and controls, respectively. The proportion of the probands with body mass index >30 was 8% for the patients, 6% for the controls. Twenty percent of the patients and 27% of the control probands were smokers at the time of blood sampling, but 95% of the patients were smokers at Ml onset. Because no influence of drugs on Lp(a) concentrations is known, with the exception of stanozolol (21) and niacin/neomycin treatment (22) , and because the patients were under various drug regimens during convalescence, we did not evaluate the effect of drugs on Lp(a)
concentrations.
No patients or control probands were being treated with stanozolol or niacinineomycin. Methods. Total cholesterol, HDL cholesterol, and serum triglycerides were measured from freshly isolated serum. Ape A!, AU, and B, Lp(a), and ape E pelymorphism were determined from samples that had been stored at -20 #{176}C for two to six months. (27) . Two groups were compared by use of the Mann-Whitney test, more than two groups were compared by use of the 29) . This distribution was markedly shifted to the right in MI survivors (Figure 1) . Because of the asymmetric distribution of Lp(a) concentrations, we calculated geometric means. The mean value for MI survivors was 0.12 gIL vs 0.05 g/L for controls. The value discriminating best between MI survivors and controls was 0.20 g/L. Of the control group, 16% had Lp(a) values >0.20 gIL, whereas 34% in the MI survivor group exceeded this level (P <0.001). As shown in Table 2 (Table 3 ) indicated Lp(a) to be an independent risk factor for MI. Table 2 ). Figure 2 shows that the Lp(a) distribution in men with low (<3.90 mmolJL) and 
LDL -cholesterol and Lp(a). No correlation between Lp(a) concentrations and LDL cholesterol was found, either in MI survivors or in controls (
Effect of apo E polymorphism
on Lp(a) and apo B concentrations. In 337 MI patients we determined values for ape B and Lp(a) as well as ape E polymorphism. Ape E phenotypes were distributed as follows: 26 subjects had the ape E 2/3 phenotype, 229 subjects the ape E 3/3 phenotype, and 82 subjects the ape E 3/4 phenotype-a distribution that does not differ from that reperted for a healthy population (30). Ape B concentration, LDL cholesterol, and the ratios for ape B/ape Al and LDL cholesterollHDL cholesterol correlated highly with the ape E phenotype (Table 4 ). In contrast, Lp(a) concentrations were not influenced by phenotypes of ape E, which, like ape B, is a ligand of the LDL receptor. Mean Lp(a) concentrations were 0.11 g/L and 0.12 g/L for the ape E 2/3 and ape E 3/4 phenotype, respectively. This difference in concentration was not statistically significant (Figure 3) . 
Discussion
It is well known that increased Lp(a) is associated with a high risk for premature development of atherosclerosis. This process is described for coronary arteries (11-18) and cerebral arteries (19, 20) . Also re-stenosis of vein grafts after bypass surgery has been reported (21) . Our study shows a close association between early onset MI and increased Lp(a). We used discriminant analysis to determine 0.20 gIL as the concentration in plasma that discriminated best between the MI group and the control subjects. In some previous studies the risk threshold level was put at 0.30 g/L (13, 15, 16 ). When one considers the differences in risk-group definition, ethnic background, and method of cutoff determination among the different studies, this degree of discrepancy may not be unexpected.
Circumstantial evidence from previously reported studies on the structure of Lp(a) led to the assumption that apo(a) is covalently linked to LDL by a disulfide bond (4). Therefore, it was interesting to investigate whether Lp(a) concentrations in plasma are subject to modulation by the same factors that influence LDL cholesterol and ape B concentrations-namely, ape E polymorphism and age. A variation in LDL cholesterol and ape B concentration, dependent on ape E polymorphism, which has been reported by our group and others (30,31), was also present in the male MI survivors. In contrast, no such variation was It appears, however, that regulatory mechanisms important in the synthesis and catabolism of lipeproteins differ between LDL-cholesterol and Lp(a).
